Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$18.52 - $22.55 $1.27 Million - $1.54 Million
-68,400 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$20.25 - $39.49 $128,000 - $249,616
-6,321 Reduced 8.46%
68,400 $1.46 Million
Q4 2020

Feb 02, 2021

BUY
$21.17 - $32.61 $104,177 - $160,473
4,921 Added 7.05%
74,721 $2.22 Million
Q3 2020

Nov 05, 2020

BUY
$18.13 - $30.61 $32,634 - $55,098
1,800 Added 2.65%
69,800 $1.51 Million
Q2 2020

Aug 12, 2020

BUY
$14.41 - $25.35 $37,076 - $65,225
2,573 Added 3.93%
68,000 $1.52 Million
Q1 2020

May 12, 2020

BUY
$13.16 - $22.9 $268,464 - $467,160
20,400 Added 45.31%
65,427 $996,000
Q4 2019

Jan 27, 2020

BUY
$19.53 - $25.5 $663,727 - $866,617
33,985 Added 307.78%
45,027 $1.03 Million
Q3 2019

Oct 31, 2019

BUY
$18.62 - $24.51 $205,602 - $270,639
11,042 New
11,042 $238,000

Others Institutions Holding RYTM

About RHYTHM PHARMACEUTICALS, INC.


  • Ticker RYTM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,720,000
  • Market Cap $3.12B
  • Description
  • Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...
More about RYTM
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.